ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1048

Estimating the Weight of Rheumatologic Diseases in Mortality in Spain: Basic Cause of Death vs Multiple Cause Analysis

ana Perez1, Fernando Albarran2, Cristina Bohorquez2, Atusa Movasat2, Lucia Ruiz2, Paula Pretel2, elena Rabadan2, Valentina Emperiale2, Adrian abbasi3, julio suarez3, lorena montano3, emilio rico3, alfredo prieto4, Inmaculada Leon5, melchor Alvarez de Mon3 and beatriz perez6, 1Hospital Universitario Príncipe de Asturias. Rheumatology. Medicine Faculty. Alcala University Department., Madrid, Spain, 2Hospital Universitario Príncipe de Asturias, Rheumatology Department, Alcala de Henares, 3Hospital Universitario Príncipe de Asturias, Madrid, Spain, 4Faculty of Medicine. Alcala University, Alcala de Henares, Spain, 5Communicable Diseases. Instituto de Salud Carlos III, Madrid, Spain, 6Department of Epidemiology of Chronic Diseases.National Center of Epidemiology/CIBERESP. Instituto de Salud Carlos III, Madrid, Spain

Meeting: ACR Convergence 2021

Keywords: Mortality, Multiple cause analysis, Systemic lupus erythematosus (SLE), Systemic sclerosis, Vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 8, 2021

Title: Epidemiology & Public Health Poster III: Other Rheumatic & Musculoskeletal Diseases (1022–1060)

Session Type: Poster Session C

Session Time: 8:30AM-10:30AM

Background/Purpose: Classical statistics provide information on mortality rates for basic causes of death. Although many inflammatory rheumatic diseases decrease life expectancy, they are generally not a direct cause of death. Since 2016, the Spanish Institute of Statistics provides information on all causes appearing on certificates, in addition to the basic one; this may help to estimate the real burden of this group of diseases on mortality in Spain.

Methods: Population estimates and individual death records for inflammatory rheumatic diseases [ICD10 M05-14; M30-36; M45-46] for 2016-2018 were available from the National Institute of Statistics. We calculated age-adjusted mortality rates by sex and by age group (0-44, 45-64 and ≥ 65) a) using only the basic cause (BC) (Table 1); and b) using the certificates in which these diseases appear anywhere, either as a basic, immediate, intermediate or fundamental cause (MCD) (Table 1). In the latter case, we also describe which are the non-rheumatic basic causes of death in the certificates mentioning rheumatic pathology (Figure1).

Results: Inflammatory rheumatic syndromes appeared in 6998 death certificates (2333 annual average, 63% women), although BC were considered in only 36% of them (833 deaths per year; 66% women), with age-adjusted mortality rates for MDC and BC of 1.56 and 0.64 deaths/100,000 inhabitants, respectively. In the certificates mentioning rheumatic pathology (MCD) in which this was not the basic cause, death was mainly attributed to cardiovascular disease (20%), cancer (12%) and respiratory diseases (10%).

Within age groups, the adjusted rate of MDC for deaths in those under 45 years of age was 0.17 per 100,000 (0.12 as a basic cause); 1.76 for the 45 to 64 range (0.85 as a basic cause); and 17.54 for those over 64 years of age (6.14 as a basic cause). Overall, the rates in women were somewhat higher, although the main differences between sexes were observed in systemic sclerosis and lupus (almost three times more frequent in women) and in spondyloarthritis (in which the male rates were double those of women). Rheumatoid arthritis, as expected, had the highest mortality in both sexes, with adjusted rates based on MDC more than three times higher than those calculated with BC alone (MDC: 0.56/100,000; BC: 0.17/100,000). The change in rates using MDC is rather less marked in the more aggressive entities, such as systemic sclerosis or systemic lupus erythematosus, and especially in deaths in persons younger than 45 years. In these subgroups, rheumatologic diseases are the basic cause of death in almost two thirds of the certificates in which they appear, and in almost 90% if we are talking about deaths in young people with systemic sclerosis.

Conclusion: At the population level, these syndromes have a non-negligible importance in terms of mortality, which is underestimated in the classic mortality statistics, based only on basic causes. The underestimation is less in the more severe rheumatologic processes. The rates provided here probably portray a picture closer to reality of the burden that these diseases represent in Spanish mortality.

Figure 1. Basic cause of death among deceases registering inflammatory rheumatic diseases in the death certificate. Spain, 2016_2018.

Table 1.Age-adjusted mortality rates in Spain in 2016_18 for all inflammatory rheumatic syndromes using MCD and BC approaches


Disclosures: a. Perez, None; F. Albarran, None; C. Bohorquez, None; A. Movasat, None; L. Ruiz, None; P. Pretel, None; e. Rabadan, None; V. Emperiale, None; A. abbasi, None; j. suarez, None; l. montano, None; e. rico, None; a. prieto, None; I. Leon, None; m. Alvarez de Mon, None; b. perez, None.

To cite this abstract in AMA style:

Perez a, Albarran F, Bohorquez C, Movasat A, Ruiz L, Pretel P, Rabadan e, Emperiale V, abbasi A, suarez j, montano l, rico e, prieto a, Leon I, Alvarez de Mon m, perez b. Estimating the Weight of Rheumatologic Diseases in Mortality in Spain: Basic Cause of Death vs Multiple Cause Analysis [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/estimating-the-weight-of-rheumatologic-diseases-in-mortality-in-spain-basic-cause-of-death-vs-multiple-cause-analysis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/estimating-the-weight-of-rheumatologic-diseases-in-mortality-in-spain-basic-cause-of-death-vs-multiple-cause-analysis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology